About Us

Treatment for cancer and blood disorders

We are the region’s only comprehensive center for childhood cancer and blood disorders 

We are a nationally recognized leader in pediatric cancer diagnosis, treatment and exceptional care.

We have cancer specialists focused on every area of childhood cancer

Our team of doctors and nurses specialize in the field of pediatric hematology/oncology (cancer and blood disorders). Each doctor has individual expertise in a different area of this specialty, so your child receives highly individualized, expert care from someone who is dedicated to a specific type of cancer or blood disorder.

We have advanced technology and expertise

Doernbecher cancer researchers and experts together with the internationally known experts at the OHSU Knight Cancer Institute, are proud to provide the newest and most advanced treatments, state-of-the-art facilities and some of the finest medical expertise in the country in the effort to make childhood cancer a thing of the past.

We offer new hope through clinical trials

We are the only program in the region to conduct phase I clinical trials, which give your child access to the newest and best treatments available because our physicians and researchers are national leaders in the search for new therapies for children's cancers. The best cancer survival rates are seen in centers where clinical trials therapies are available.

We are a member of the Children’s Oncology Group (COG), an international research organization affiliated with the National Cancer Institute, devoted to creating new treatments and cures for cancers that affect children. Many of our doctors help design these treatments and measure their results. We are the only program in the region with this level of expertise.

We are also the only members in Oregon of the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) consortium. TACL is comprised of a group of children’s hospitals and universities that work closely together to rapidly develop and carry out clinical trials. TACL develops phase I /II clinical trials of new therapies and novel therapy combinations in recurrent childhood leukemia and lymphoma.

Additionally, we are members of in Oregon the Pacific Pediatric Neuro-Oncology Consortium (PNOC). PNOC is a network of 15 children’s hospitals that conduct clinical trials of new therapies for children with brain tumors. Their goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.

We offer developmental therapeutics

We are one of only 21 hospitals in the country approved by the National Cancer Institute to participate in the COG Phase I Consortium. This allows us to offer our patients with progressive disease, the opportunity to be treated with investigational agents.

We are family centered and kid friendly

As the children’s hospital that more Oregonians trust with their child’s healthcare, we understand that kids need more than good medicine for healing. That’s why we also do everything we can for your child’s psychological, developmental and social needs, as well as providing support services to you and your family. We also know that you are your child’s most important source of support, and we encourage your involvement in your child’s care. Learn more about family centered care at OHSU